NCT00666627View on ClinicalTrials.gov

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

PHASE2CompletedINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2014

Conditions
Post-menopausal Osteoporosis
Interventions
DRUG

Ibandronate

once monthly

DRUG

Risedronate

Risedronate 35mg once weekly

DRUG

Alendronate

Alendronate 70mg once weekly

Trial Locations (1)

S5 7AU

Academic Unit of Bone Metabolism (Sheffield), Sheffield

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT00666627 - Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects | Biotech Hunter | Biotech Hunter